However, the substantial weight loss observed with GLP-1 RAs surged its off-label prescription for obesity and weight management, leading to price increases, global shortages, and creation of black markets to supply demand (9, 10). The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.